An observational study in Caesarean Section, sponsored by Oslo University Hospital. Enrolling by invitation at 1 site in Norway. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by Oslo University Hospital · Observational
Among 17 studies in Patient Satisfaction with a site in Norway — 2 open to participants now, 3 under way, none of them phase 3. Patient Satisfaction · Norway.
Among the 17 studies in Patient Satisfaction with a site in Norway, this one is the only one that started in 2026, is one of 3 observational ones, and was the 17th registered.
877 studies on the registry are indexed under Patient Satisfaction; 202 are open to participants now.
Browse Patient Satisfaction studies →2 of the 17 studies in Patient Satisfaction with a site in Norway are open now. Recruiting first, the newest first:
St. Olavs Hospital · Sites in Norway
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 99 Patient Satisfaction studies recruiting now, 61 (62%) set no upper age limit and 30 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 50 Years · female.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 700 is above the median of 149 across 225 observational studies indexed under Patient Satisfaction.
Median enrollment 133 across the 14 interventional studies, 99 across the 3 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
Oslo University Hospital is the lead sponsor of 834 studies on the registry; 149 are open to participants now.
Oslo University Hospital has 3 studies filed under Patient Satisfaction — fewer than ten, so there is no comparison to draw.
2 of the studies in Patient Satisfaction with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06839820University Hospital, AkershusInfliximab Infusion Rates in Pediatric Inflammatory Bowel Disease | 2026-12 |
| NCT06212687St. Olavs HospitalEvaluation of a Digital Pre-therapy Patient Education Program (StartHjelp) in Outpatient Mental Health Care | 2026-12 |
Among the 17 studies in Patient Satisfaction with a site in Norway, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of the study is to assess patient reported outcomes after caesarean section using self report questionnaire.
The project consists of two studies: Study 1 explores patient reported outcomes after caesarean section related to recovery and quality of care. Study 2 explores possible associations between perioperative hypothermia during caesarean section and postoperative infection
Females giving birth through caesarean section
Inclusion Criteria: Caesarean section surgery -
Exclusion Criteria: Stillborn baby, baby admitted to neonatal intensive care,
-
No intervention
Patient reported recovery after caesarean delivery and symptoms of post caesarean infection
Data collection using questionnaire
Time frame: Data collection 24 hours after surgery and 7 days after surgery and 30 days after surgery
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Nov 2030, 58 months after the start.
Of 105 non-industry observational studies under Patient Satisfaction, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's planned 58 months is above that.
Counting every sponsor, half of 111 studies reached it within 20 months; a quarter within 7 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.